Eugene Stroke & Thrombosis Institutional Sales Consultant
Bayer
A complete application in a minute
Tailored resume and cover letter, ready to send.
Benefits offered by this job
Job summary
Bayer is seeking an Institutional & Specialty Pharmaceutical Sales Consultant to cover Eugene, OR, focusing on stroke and thrombosis. You will build relationships with hospitals and health systems, lead formulary discussions, and drive launch activities. A strong background in biotech/pharma sales and credentialing is required.
This role offers competitive compensation, robust benefits, and opportunities to shape a new commercial organization in a dynamic market.
Qualifications
- Bachelor's degree or 10 years of relevant sales experience; hospital/health system exposure preferred.
- Experience selling into hospitals, health systems, or institutional accounts.
- Strong communication, presentation, and stakeholder engagement skills.
- Ability to meet credentialing and safety requirements; valid driver's license.
Responsibilities
- Drive clinical demand, education, and sales by communicating the value of Asundexian in stroke prevention.
- Lead formulary access by navigating P&T committees and influencing protocol adoption across health systems.
- Build strategic relationships with priority institutions and key stakeholders and neurologists.
- Develop territory business plans based on local market insights and collaborate with internal teams.
- Demonstrate disease-state and market knowledge with analytics to identify opportunities and risks.
- Analyze competitive landscape and proactively identify opportunities and risks.
Skills
Education
Job description
Bayer is seeking an Institutional & Specialty Pharmaceutical Sales Consultant to cover Eugene, OR, focusing on stroke and thrombosis. You will build relationships with hospitals and health systems, lead formulary discussions, and drive launch activities. A strong background in biotech/pharma sales and credentialing is required.
This role offers competitive compensation, robust benefits, and opportunities to shape a new commercial organization in a dynamic market.
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
